Showing results (1-10 of 363) with videos related to

Sort By:
Pageof 37
Taiwanese Journal of Obstetrics & Gynecology|September 10, 2022
Trial of labor after cesarean sectionWen-Hsun Chang, Szu-Ting Yang, Peng-Hui Wang
Taiwanese Journal of Obstetrics & Gynecology|March 6, 2025
Menopause part I: Vasomotor symptoms (I)Peng-Hui Wang, Szu-Ting Yang, Wen-Hsun Chang, et al.
Taiwanese Journal of Obstetrics & Gynecology|January 30, 2026
Mirvetuximab soravtansine-Gynx (MIRV) for treating platinum-resistant recurrent ovarian cancerPeng-Hui Wang, Che-Wei Chang, Szu-Ting Yang, et al.
Taiwanese Journal of Obstetrics & Gynecology|January 10, 2025
Transcervical resection of myoma (TCRM): Part IPeng-Hui Wang, Szu-Ting Yang, Wen-Hsun Chang, et al.
Taiwanese Journal of Obstetrics & Gynecology|May 14, 2025
Endometrial cancer: Part II. Multimodality treatment of uterine high-grade serous carcinoma (clinical course II)Che-Wei Chang, Szu-Ting Yang, Wen-Hsun Chang, et al.
Taiwanese Journal of Obstetrics & Gynecology|January 10, 2025
Transcervical resection of myoma (TCRM): Part IIPeng-Hui Wang, Szu-Ting Yang, Wen-Hsun Chang, et al.
Taiwanese Journal of Obstetrics & Gynecology|March 6, 2025
Overcoming extensive abdominal adhesions: Utilizing mini-wound techniques for successful laparoscopic staging in cancer surgeryKai-Chung Huang, Yu-Ting Lin, Wen-Hsun Chang, et al.
Taiwanese Journal of Obstetrics & Gynecology|September 23, 2019
Paclitaxel-related nail toxicitySzu-Ting Yang, Min Cheng, Na-Rong Lee, et al.
Taiwanese Journal of Obstetrics & Gynecology|November 26, 2023
Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125Szu-Ting Yang, Wen-Hsun Chang, Fang-Wei Chou, et al.
Taiwanese Journal of Obstetrics & Gynecology|January 12, 2024
Front-line chemoimmunotherapy for treating epithelial ovarian cancer: Part II promising results of phase 2 study of paclitaxel-carboplatin-oregovomab regimenSzu-Ting Yang, Wen-Hsun Chang, Fang-Wei Chou, et al.
Pageof 37